Aperion Biologics


Aperion Biologics develops and manufactures tissue-derived medical products and distributes research reagents. The company describes a proprietary immunochemical tissue-processing method to reduce antigenicity of non-primate animal grafts, maintains an issued and pending patent portfolio covering tissue treatment, and reports capabilities in tissue processing, implant development, histology methods, immunoassay development, preclinical studies, and quality/regulatory systems.

Industries

biotechnology
health-care
medical-device

Nr. of Employees

small (1-50)

Aperion Biologics

San Antonio, Texas, United States, North America


Products

Human Arginase ELISA kit

Competitive ELISA kit for detection of human arginase in serum, plasma, cell culture supernatant, body fluids and tissue homogenate; includes assay performance parameters and storage/sample handling guidance.

Mouse Anti-KLH IgG ELISA kit

Solid-phase indirect ELISA for detection of anti-KLH IgG in mouse serum or plasma; strip-well format for up to 96 tests with reported within- and between-assay precision.


Services

Custom ELISA development

Custom design and development of ELISA assays for additional species or antibody isotypes and custom sample testing for IgG/IgM/IgA or total antibody measurements.

Expertise Areas

  • Xenograft processing and humanization
  • Allograft manufacturing and scale-up
  • Tissue deantigenation and sterilization
  • Orthopedic tissue-implant development
  • Show More (5)

Key Technologies

  • Immunochemical tissue modification
  • Alpha-galactosidase-mediated antigen removal
  • ELISA immunoassays
  • Histological staining methods (Papanicolaou, H&E, PAS, Oil Red O, diceCT)
  • Show More (4)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.